Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Aydin Harston combines his love for science and technology with legal expertise to advocate for his clients in all matters necessary to grow, protect, and defend their businesses. With a Ph.D. in biochemistry and numerous scientific and legal publications, Aydin seeks to produce creative and effective approaches to achieve his clients' goals as efficiently as possible.
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has…
Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare DiseasesFederal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with…
Continue Reading Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole ActGene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and…
Continue Reading The Evolving Gene Editing Landscape: From Research Tool to MarketOn July 27, 2021, Amgen announced that it will acquire Bay area-based Teneobio, a privately held, clinical stage biotechnology…
Continue Reading Amgen Acquires Multispecific Immunotherapy Biotech Startup TeneoBio
Elizabeth Holmes, former CEO of the now-defunct blood-testing technology company Theranos, recently learned a harsh lesson on the complexities and…
Continue Reading Pitfalls of Attorney-Client Privilege and Tips for Corporate Officers and Employees
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the…
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Centripetal Networks, Inc. (“Centripetal”), one of the fastest growing innovators in the cybersecurity space, leveraged its patent portfolio against Cisco…
Continue Reading Lessons Learned From Centripetal’s Multi-Billion Dollar Damages Award Against Cisco
In the fast-paced and dynamic environment of startup and emerging companies, standard operating procedures and compliance matters may often fall…
Continue Reading Is it Time to Re-evaluate (or Create) Your Document Retention Policy?
On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,…
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.